lansoprazole has been researched along with Plasma Cell Tumor in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, K | 1 |
| Sugitani, M | 1 |
| Nagata, T | 1 |
| Nishinarita, S | 1 |
| Kawamura, F | 1 |
| Takahashi, Y | 1 |
| Ishii, Y | 1 |
| Kawamura, Y | 1 |
| Komuro, S | 1 |
| Yanai, M | 1 |
| Nemoto, N | 1 |
| Arakawa, Y | 1 |
1 other study available for lansoprazole and Plasma Cell Tumor
| Article | Year |
|---|---|
A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Biopsy, Needle; Clarithromycin; Drug Therapy, | 2001 |